GRI Bio, Inc. Common Stock (NASDAQ: GRI) last traded at $1.65, down 1.20% on the session. The quote above updates while this page is open; the figures below are drawn from GRI Bio, Inc. Common Stock’s own filings and are restated only when a new one is published.
GRI Bio, Inc. Common Stock trades on NASDAQ under the ticker GRI. Its market capitalisation is $3.61 million.
Valuation measures for GRI Bio, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.61M |
|---|---|
| Enterprise value | -$6.24M |
| Price / book | 0.35 |
| Beta | 0.95 |
Trailing-twelve-month figures tagged in GRI Bio, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$9.66M |
|---|---|
| Return on equity | -93.96% |
| Cash | $10.95M |
Range and volume for GRI over the past 52 weeks.
| 52-week high | $80.36 |
|---|---|
| 52-week low | $1.36 |
| Volume | 82.4K |
| Average volume | 181.4K |
| Previous close | $1.67 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.